Title: Clinical Effect Observation of Qiliqiangxin Capsule in the Treatment of Refractory Heart Failure
Abstract: Objective To observe the clinical effect of Qiliqiangxin capsule in the treatment of refractory heart failure(RHF).Methods 86 RHF patients admitted to our hospital from June 2012 to May 2014 were selected and divided into observation group and control group according to the admission sequence, with 43 cases in each group. The control group was given conventional symptomatic treatment, the observation group was given Qiliqiangxin capsule on the basis of conventional therapy, 2 weeks as a course, and 3 course at least. The cardiac function and short-term efficacy of two groups after 4 weeks of the treatment were compared, the long-term efficacy of two groups after following up for 6 months were also compared. Results After 4 weeks of the treatment, the LVEF, LVESV, SV and HR of observation group were significantly higher than those of control group, with statistical difference(P 0.05); the effective rate and total effective rate of observation group were 46.51%, 97.67% respectively, significantly higher than 23.26% and 83.72% of control group, with statistical difference(P 0.05). After 3 months and 6 months, the readmission cases of observation group were significantly lower than those of control group(P 0.05), but the death tolls of two groups had no statistical difference(P 0.05). The walking distance of 6MWT of observation group after following up for 6 months was significantly better than that of control group, with statistical difference(P 0.05).Conclusions Qiliqiangxin capsule has good short-term efficacy and long-term efficacy in the treatment of patients with refractory heart failure, without significant side effects, which can be promotion in clinic.
Publication Year: 2015
Publication Date: 2015-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot